Ubenimex
Catalog No. A10958
Ubenimex,也称为NK 421和Bestatin,是CD13抑制剂。Ubenimex通过抑制脂质吞噬相关机制中的Akt信号传导减弱肾细胞癌中获得性索拉非尼耐药性。Ubenimex协同增强抗癌药在肝细胞癌中的作用。Ubenimex通过抑制APN的表达并诱导前列腺癌细胞的自噬细胞死亡来抑制细胞增殖,迁移和侵袭。
Catalog Num | A10958 |
---|---|
M. Wt | 308.378 |
Formula | C16H24N2O4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 58970-76-6 |
Synonyms | Ubenimex, NK 421, NK-421, NK421, Bestatin, NSC 265489, NSC265489, NSC-265489 |
SMILES | CC(C)C[C@@H](C(O)=O)NC([C@@H](O)[C@H](N)CC1=CC=CC=C1)=O |
Ubenimex,也称为NK 421和Bestatin,是CD13抑制剂。Ubenimex通过抑制脂质吞噬相关机制中的Akt信号传导减弱肾细胞癌中获得性索拉非尼耐药性。Ubenimex协同增强抗癌药在肝细胞癌中的作用。Ubenimex通过抑制APN的表达并诱导前列腺癌细胞的自噬细胞死亡来抑制细胞增殖,迁移和侵袭。
In vitro | DMSO | 0.35 mg/mL (1.13 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 32.43 mL | 162.14 mL | 324.28 mL |
0.5 mM | 6.49 mL | 32.43 mL | 64.86 mL |
1 mM | 3.24 mL | 16.21 mL | 32.43 mL |
5 mM | 0.65 mL | 3.24 mL | 6.49 mL |
*The above data is based on the productmolecular weight 308.378. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.